DrugPatentWatch Database Preview
Litigation Details for HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)
» See Plans and Pricing
HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)
| Docket | Start Trial | Date Filed | 2015-03-23 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
| Jury Demand | None | Referred To | Douglas E. Arpert |
| Parties | EMCURE PHARMACEUTICALS USA, INC.; EMCURE PHARMACEUTICALS LIMITED; EXELA HOLDINGS, INC.; EXELA PHARMA SCIENCES, LLC; EXELA PHARMSCI, INC.; FRESENIUS KABI USA, LLC; HELSINN HEALTHCARE S.A.; HOSPIRA WORLDWIDE, INC.; HOSPIRA, INC.; ROCHE PALO ALTO LLC | ||
| Patents | 6,063,802; 6,132,758; 6,284,770; 6,294,548; 7,947,724; 7,947,725; 7,960,424; 8,518,981; 8,598,219; 8,729,094 | ||
| Attorneys | ALLISON LINDA HOLLOWS; ANGELA CHERYL NI; ARNOLD B. CALMANN; CHARLES MICHAEL LIZZA; DAVID C. KISTLER; ERIC W. DITTMANN; GARY J. RUCKELSHAUS; ISAAC SAMUEL ASHKENAZI; JEFFREY S. SOOS; KAREN A. CONFOY; KATHERINE ANN ESCANLAR; LEE A. GOLDBERG; SARAH ANN SULLIVAN; STEVEN JAMES LINK; WILLIAM C. BATON | ||
| Firms | Blank Rome LLP; Fox Rothschild LLP; Fox Rothschild LLP, Pc; Heritage Pharmaceuticals Inc.; Merchant & Gould Pc | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. HOSPIRA, INC.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-03-23 | 1 | , 5,622,720, 5,955,488, and 6,063,802. Commer- rently pending U.S. patent application Ser. No. 11/186,311…Rancate (CH); 6,063,802 A 5/2000 Winterborn . … 5,922,749, 5,622,720, 5,955,488, and 6,063,802. Commer- ence. …Winterborn . 514/399 6,063,802 A 5/2000 Winterborn . …Winterborn . 514/399 6,063,802 A 5/2000 Winterborn . | External link to document | |
| 2016-04-05 | 86 | United States Patent No. 7,947,724 (“the ‘724 patent”), No. 7,947,725 (“the ‘725 patent”), No. 7,960,…“the ‘424 patent”), No. 8,598,219 (“the ‘219 patent”), and No. 8,729,094 (“the ‘094 patent”) (collectively…other assignee of the Aloxi® patents. (See dkt. 22 at 6.) The Aloxi® patents claim various formulations…Aloxi® patents; (2) Defendants’ paragraph IV notice letter allegations that the Aloxi® patents are invalid…(b) of the Patent Act provides that: “Whoever actively induces infringement of a patent shall be liable | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
